Box score
Asher Biotherapeutics, Inc.
Reported $55M sold in a new Form D filed April 16, 2024 (South San Francisco, California).
- Biggest raise
- $55M filed Apr 16, 2024
- League
- Bio & Health Biotechnology
- Based in
- South San Francisco, California
- Season rank
- #91 of 1,389 in the Bio & Health League; #352 of 12,443 overall (2024)
- Incorporated
- 2019
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2024-04-16 | New notice | $55M | $55M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1787260.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Attralus, Inc. | Bio & Health | $56M |
| 2 | Aeovian Pharmaceuticals, Inc. | Bio & Health | $50.4M |
| 3 | Route 92 Medical, Inc. | Bio & Health | $50.4M |
| 4 | Solve Therapeutics, Inc. | Bio & Health | $50.4M |
| 5 | Unicycive Therapeutics, Inc. | Bio & Health | $50M |
| 6 | Eledon Pharmaceuticals, Inc. | Bio & Health | $50M |